This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 Oct;21(10):1359-1361.

doi: 10.1080/14760584.2022.2112571. Epub 2022 Aug 16.

COVID-19 vaccine design and vaccination strategy for emerging variants

Vivek P Chavda¹, Vasso Apostolopoulos^{2

3}

Affiliations

Affiliations

¹ Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad, India.
² Institute for Health and Sport, Victoria University, Melbourne, Australia.
³ Immunology Program, Australian Institute for Musculoskeletal Science (AIMSS) , Melbourne, Australia.

PMID: 35949150
DOI: 10.1080/14760584.2022.2112571

Editorial

COVID-19 vaccine design and vaccination strategy for emerging variants

Vivek P Chavda et al. Expert Rev Vaccines. 2022 Oct.

. 2022 Oct;21(10):1359-1361.

doi: 10.1080/14760584.2022.2112571. Epub 2022 Aug 16.

Authors

Vivek P Chavda¹, Vasso Apostolopoulos^{2

3}

Affiliations

¹ Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad, India.
² Institute for Health and Sport, Victoria University, Melbourne, Australia.
³ Immunology Program, Australian Institute for Musculoskeletal Science (AIMSS) , Melbourne, Australia.

PMID: 35949150
DOI: 10.1080/14760584.2022.2112571

No abstract available

PubMed Disclaimer

Similar articles

Antibody responses to Sputnik Vaccination in naïve and COVID 19-recovered vaccine recipients, India.
Sapkal G, Deshpande GR, Tilekar B, Yadav P, Abraham P, Salunke A, Patil C, Deshpande K, Patil R, Pawar N, Joshi A, Vaidya A, Shivankar A. Sapkal G, et al. J Travel Med. 2022 May 31;29(3):taac040. doi: 10.1093/jtm/taac040. J Travel Med. 2022. PMID: 35325194 Free PMC article. No abstract available.
Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
Li Q, Wang J, Tang Y, Lu H. Li Q, et al. Drug Discov Ther. 2021;15(3):118-123. doi: 10.5582/ddt.2021.01058. Drug Discov Ther. 2021. PMID: 34234059 Review.
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.
Jalkanen P, Kolehmainen P, Haveri A, Huttunen M, Laine L, Österlund P, Tähtinen PA, Ivaska L, Maljanen S, Reinholm A, Belik M, Smura T, Häkkinen HK, Ortamo E, Kantele A, Julkunen I, Lempainen J, Kakkola L. Jalkanen P, et al. Microbiol Spectr. 2022 Apr 27;10(2):e0225221. doi: 10.1128/spectrum.02252-21. Epub 2022 Mar 9. Microbiol Spectr. 2022. PMID: 35262410 Free PMC article.
Primary COVID-19 vaccine cycle and booster doses efficacy: analysis of Italian nationwide vaccination campaign.
Mattiuzzi C, Lippi G. Mattiuzzi C, et al. Eur J Public Health. 2022 Apr 1;32(2):328-330. doi: 10.1093/eurpub/ckab220. Eur J Public Health. 2022. PMID: 34978571 Free PMC article.
COVID-19 vaccines: concerns beyond protective efficacy and safety.
Lai CC, Chen IT, Chao CM, Lee PI, Ko WC, Hsueh PR. Lai CC, et al. Expert Rev Vaccines. 2021 Aug;20(8):1013-1025. doi: 10.1080/14760584.2021.1949293. Epub 2021 Jul 5. Expert Rev Vaccines. 2021. PMID: 34180347 Review.

See all similar articles

Cited by

The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far.
Chavda VP, Bezbaruah R, Deka K, Nongrang L, Kalita T. Chavda VP, et al. Vaccines (Basel). 2022 Nov 14;10(11):1926. doi: 10.3390/vaccines10111926. Vaccines (Basel). 2022. PMID: 36423021 Free PMC article. Review.
mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
Chavda VP, Jogi G, Dave S, Patel BM, Vineela Nalla L, Koradia K. Chavda VP, et al. Vaccines (Basel). 2023 Feb 22;11(3):507. doi: 10.3390/vaccines11030507. Vaccines (Basel). 2023. PMID: 36992091 Free PMC article. Review.
The Vaccine World of COVID-19: India's Contribution.
Chavda VP, Vihol DR, Solanki HK, Apostolopoulos V. Chavda VP, et al. Vaccines (Basel). 2022 Nov 17;10(11):1943. doi: 10.3390/vaccines10111943. Vaccines (Basel). 2022. PMID: 36423038 Free PMC article. Review.
Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management.
Chavda VP, Balar P, Vaghela D, Solanki HK, Vaishnav A, Hala V, Vora L. Chavda VP, et al. Vaccines (Basel). 2023 Jan 11;11(1):160. doi: 10.3390/vaccines11010160. Vaccines (Basel). 2023. PMID: 36680006 Free PMC article. Review.
Nanoparticle-Based Delivery Systems for Vaccines.
Bezbaruah R, Chavda VP, Nongrang L, Alom S, Deka K, Kalita T, Ali F, Bhattacharjee B, Vora L. Bezbaruah R, et al. Vaccines (Basel). 2022 Nov 17;10(11):1946. doi: 10.3390/vaccines10111946. Vaccines (Basel). 2022. PMID: 36423041 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information